NCT00054808
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
- Locations
-
- Genta Berkeley Heights, New Jersey, United States
Clinical trial condition
Lymphoma
Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.
2,141 public trials
305 recruiting studies
Lymphoma trial results
Completed
Study of Intravenous BCX-1777 in Relapsed or Refractory Aggressive T-Cell Leukemias or Lymphomas
NCT00035022
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- M.D. Anderson Cancer Center Houston, Texas, United States
Completed
Ultrasound Biomicroscopy - Apoptosis
NCT00188370
- Conditions
- Carcinoma, Carcinoma, Basal Cell, Hemic and Lymphatic Diseases, +20 more
- Locations
-
- Princess Margaret Hospital Toronto, Ontario, Canada
Completed
Subcutaneous Amifostine Safety Study
NCT00158041
- Conditions
- Cardiovascular Diseases, Digestive System Diseases, Exanthema, +30 more
- Locations
-
- Mt. Sinai Medical Center Miami Beach, Florida, United States
Active, Not Recruiting
An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis
NCT02808780
- Conditions
- Colitis, Colitis, Ulcerative, Colonic Diseases, +14 more
- Locations
-
- Murrieta, California, United States
- Rialto, California, United States
- Ventura, California, United States
- Coral Gables, Florida, United States
Active, Not Recruiting
A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma
NCT06425302
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Local Institution - 0152 Birmingham, Alabama, United States
- Local Institution - 0055 Anchorage, Alaska, United States
- Local Institution - 0180 Phoenix, Arizona, United States
- Local Institution - 0190 Tucson, Arizona, United States
Active, Not Recruiting
Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma
NCT03696784
- Conditions
- Chemically-Induced Disorders, Cytokine Release Syndrome, Hemic and Lymphatic Diseases, +17 more
- Locations
-
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States
Active, Not Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
NCT02465060
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Lymphoma, +138 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Thomas Hospital Fairhope, Alabama, United States
- Mobile Infirmary Medical Center Mobile, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
Active, Not Recruiting
Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer
NCT00039676
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +27 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
- NIH National Cancer Institute - Shady Grove Rockville, Maryland, United States
Active, Not Recruiting
Testing AZD1775 as a Potential Targeted Treatment in Cancers With BRCA Genetic Changes (MATCH-Subprotocol Z1I)
NCT04439227
- Conditions
- Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Blood Protein Disorders, +22 more
- Locations
-
- ECOG-ACRIN Cancer Research Group Philadelphia, Pennsylvania, United States